Event Details

August 01, 2016

Description

DEA announced a new policy designed to increase the number of DEA-registered cannabis cultivators.

Participants (1)

Name Type Mentions
DEA organization 172 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_024721.jpg

Investment Research Report / Industry Analysis • 2.28 MB
View

This document is page 85 of a 2017 report by Ackrell Capital regarding the U.S. legal landscape for cannabis. It discusses the path to federal legalization, analyzing the roles of the DEA and FDA, the conflict between state and federal regulations, and the bureaucratic hurdles stalling the approval of cannabis-derived drugs under the leadership of Attorney General Jeff Sessions. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional oversight committee.

Related Events

Events with shared participants

Enactment of the CSA; THC listed on Schedule I.

1970-01-01 • United States

View

DEA purportedly amended regulatory definition of THC to include natural occurrences.

2003-01-01 • United States

View

Holding in Hemp Industries Association v. DEA enjoining DEA enforcement of 2003 amendment.

2004-01-01 • Ninth Circuit

View

DEA announced new policy to increase number of registered cannabis cultivators.

2016-08-01 • United States

View

Barrett joined interagency task force monitoring Cuba embargo.

1998-01-01 • USA

View

DEA adopted a new policy designed to increase the number of DEA-registered cannabis cultivators.

2016-01-01 • United States

View

General Idea Show. Spring 2011 men's collection.

Date unknown • Lincoln Center Plaza, West 65th St. and Broadway, New York

View

DEA Special Agent in St. Thomas interested in Epstein and his aircraft (approximate date 2015/2016).

2015-01-01 • St. Thomas, USVI

View

Event Metadata

Type
Unknown
Location
United States
Significance Score
5/10
Participants
1
Source Documents
1
Extracted
2025-11-21 00:23

Additional Data

Source
HOUSE_OVERSIGHT_024721.jpg
Date String
August 2016

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event